Literature DB >> 26728967

Probing the interaction between cHAVc3 peptide and the EC1 domain of E-cadherin using NMR and molecular dynamics simulations.

Ahmed Alaofi1, Elinaz Farokhi1, Vivitri D Prasasty1,2, Asokan Anbanandam3, Krzysztof Kuczera4, Teruna J Siahaan1.   

Abstract

The goal of this work is to probe the interaction between cyclic cHAVc3 peptide and the EC1 domain of human E-cadherin protein. Cyclic cHAVc3 peptide (cyclo(1,6)Ac-CSHAVC-NH2) binds to the EC1 domain as shown by chemical shift perturbations in the 2D 1H,-15N-HSQC NMR spectrum. The molecular dynamics (MD) simulations of the EC1 domain showed folding of the C-terminal tail region into the main head region of the EC1 domain. For cHAVc3 peptide, replica exchange molecular dynamics (REMD) simulations generated five structural clusters of cHAVc3 peptide. Representative structures of cHAVc3 and the EC1 structure from MD simulations were used in molecular docking experiments with NMR constraints to determine the binding site of the peptide on EC1. The results suggest that cHAVc3 binds to EC1 around residues Y36, S37, I38, I53, F77, S78, H79, and I94. The dissociation constants (Kd values) of cHAVc3 peptide to EC1 were estimated using the NMR chemical shifts data and the estimated Kds are in the range of .5 × 10-5-7.0 × 10-5 M.

Entities:  

Keywords:  E-cadherin binding; NMR; blood–brain barrier; cyclic HAV peptide; molecular dynamics

Mesh:

Substances:

Year:  2016        PMID: 26728967      PMCID: PMC5061580          DOI: 10.1080/07391102.2015.1133321

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  26 in total

1.  C-cadherin ectodomain structure and implications for cell adhesion mechanisms.

Authors:  Titus J Boggon; John Murray; Sophie Chappuis-Flament; Ellen Wong; Barry M Gumbiner; Lawrence Shapiro
Journal:  Science       Date:  2002-04-18       Impact factor: 47.728

2.  Interaction between calcium-free calmodulin and IQ motif of neurogranin studied by nuclear magnetic resonance spectroscopy.

Authors:  Yanfang Cui; Jian Wen; Kong Hung Sze; David Man; Donghai Lin; Maili Liu; Guang Zhu
Journal:  Anal Biochem       Date:  2003-04-15       Impact factor: 3.365

Review 3.  NMR methods for the determination of protein-ligand dissociation constants.

Authors:  Lee Fielding
Journal:  Curr Top Med Chem       Date:  2003       Impact factor: 3.295

4.  The crystal structure of human E-cadherin domains 1 and 2, and comparison with other cadherins in the context of adhesion mechanism.

Authors:  Emilio Parisini; Jonathan M G Higgins; Jin-huan Liu; Michael B Brenner; Jia-huai Wang
Journal:  J Mol Biol       Date:  2007-08-21       Impact factor: 5.469

Review 5.  CHARMM: the biomolecular simulation program.

Authors:  B R Brooks; C L Brooks; A D Mackerell; L Nilsson; R J Petrella; B Roux; Y Won; G Archontis; C Bartels; S Boresch; A Caflisch; L Caves; Q Cui; A R Dinner; M Feig; S Fischer; J Gao; M Hodoscek; W Im; K Kuczera; T Lazaridis; J Ma; V Ovchinnikov; E Paci; R W Pastor; C B Post; J Z Pu; M Schaefer; B Tidor; R M Venable; H L Woodcock; X Wu; W Yang; D M York; M Karplus
Journal:  J Comput Chem       Date:  2009-07-30       Impact factor: 3.376

Review 6.  Using chemical shift perturbation to characterise ligand binding.

Authors:  Mike P Williamson
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2013-03-21       Impact factor: 9.795

7.  Modulation of intercellular junctions by cyclic-ADT peptides as a method to reversibly increase blood-brain barrier permeability.

Authors:  Marlyn D Laksitorini; Paul K Kiptoo; Ngoc H On; James A Thliveris; Donald W Miller; Teruna J Siahaan
Journal:  J Pharm Sci       Date:  2015-01-12       Impact factor: 3.534

Review 8.  Application of NMR and molecular docking in structure-based drug discovery.

Authors:  Jaime L Stark; Robert Powers
Journal:  Top Curr Chem       Date:  2012

9.  Enhancement of drug absorption through the blood-brain barrier and inhibition of intercellular tight junction resealing by E-cadherin peptides.

Authors:  Paul Kiptoo; Ernawati Sinaga; Anna M Calcagno; Hong Zhao; Naoki Kobayashi; Usman S F Tambunan; Teruna J Siahaan
Journal:  Mol Pharm       Date:  2010-12-17       Impact factor: 4.939

10.  Comparison of Linear and Cyclic His-Ala-Val Peptides in Modulating the Blood-Brain Barrier Permeability: Impact on Delivery of Molecules to the Brain.

Authors:  Ahmed Alaofi; Ngoc On; Paul Kiptoo; Todd D Williams; Donald W Miller; Teruna J Siahaan
Journal:  J Pharm Sci       Date:  2016-02       Impact factor: 3.534

View more
  2 in total

1.  Improving In Vivo Brain Delivery of Monoclonal Antibody Using Novel Cyclic Peptides.

Authors:  Kavisha R Ulapane; Brian M Kopec; Teruna J Siahaan
Journal:  Pharmaceutics       Date:  2019-10-31       Impact factor: 6.321

2.  Improving Brain Delivery of Biomolecules via BBB Modulation in Mouse and Rat: Detection using MRI, NIRF, and Mass Spectrometry.

Authors:  Kavisha R Ulapane; Ngoc On; Paul Kiptoo; Todd D Williams; Donald W Miller; Teruna J Siahaan
Journal:  Nanotheranostics       Date:  2017-06-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.